These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37829693)

  • 1. Efficacy and safety of left atrial appendage closure compared with oral anticoagulation in atrial fibrillation: a meta-analysis of randomized controlled trials and propensity-matched studies.
    Franchin L; Piroli F; Demola P; Mantovani F; Iannaccone M; Manfredi R; D'Ascenzo F; Fortuni F; Ugo F; Meucci F; Navazio A; Boccuzzi G
    Front Cardiovasc Med; 2023; 10():1212161. PubMed ID: 37829693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Outcomes of Randomized Controlled Trials Comparing Percutaneous Left Atrial Appendage Closure to Oral Anticoagulation for Nonvalvular Atrial Fibrillation: A Meta-Analysis.
    Madhavan MV; Howard JP; Brener MI; Der Nigoghossian C; Chen S; Makkar R; Osmancik P; Reddy VY; Holmes DR; Stone GW; Leon MB; Ahmad Y
    Struct Heart; 2023 Jan; 7(1):100096. PubMed ID: 37275318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation.
    Osmancik P; Herman D; Neuzil P; Hala P; Taborsky M; Kala P; Poloczek M; Stasek J; Haman L; Branny M; Chovancik J; Cervinka P; Holy J; Kovarnik T; Zemanek D; Havranek S; Vancura V; Opatrny J; Peichl P; Tousek P; Lekesova V; Jarkovsky J; Novackova M; Benesova K; Widimsky P; Reddy VY;
    J Am Coll Cardiol; 2020 Jun; 75(25):3122-3135. PubMed ID: 32586585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the Efficacy and Safety of Left Atrial Appendage Closure and Direct Oral Anticoagulants for Atrial Fibrillation: A Meta-Analysis of Randomized Control Trials and Observational Studies.
    Wei CR; Lim R; Khan S; Ahsan SA; Al Omari M; Sherpa ND; Rashid Z; Khan A
    Cureus; 2023 Dec; 15(12):e49827. PubMed ID: 38164321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials.
    Reddy VY; Doshi SK; Kar S; Gibson DN; Price MJ; Huber K; Horton RP; Buchbinder M; Neuzil P; Gordon NT; Holmes DR;
    J Am Coll Cardiol; 2017 Dec; 70(24):2964-2975. PubMed ID: 29103847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Left Atrial Appendage Closure and Oral Anticoagulation After Atrial Fibrillation Catheter Ablation.
    Fei ZT; Yao PC; Qiu JH; Chen M; Fei YD; Li W; Zhang PP; Sun J; Wang QS; Li YG
    Am J Cardiol; 2023 Oct; 204():312-319. PubMed ID: 37567023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left Atrial Appendage Closure Versus Oral Anticoagulation in Non-Valvular Atrial Fibrillation: A Systematic Review and Meta-Analysis.
    Al-Abcha A; Saleh Y; Elsayed M; Elshafie A; Herzallah K; Baloch ZQ; Banga S; Rayamajhi S; Abela GS
    Cardiovasc Revasc Med; 2022 Mar; 36():18-24. PubMed ID: 33903038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Actual management costs of patients with non-valvular atrial fibrillation treated with percutaneous left atrial appendage closure or oral anticoagulation.
    D'Ancona G; Arslan F; Safak E; Weber D; Al Ammareen R; Ince H
    Int J Cardiol; 2022 Mar; 351():61-64. PubMed ID: 34929249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
    Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
    JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of left atrial appendage closure versus medical treatment in atrial fibrillation: a network meta-analysis from randomised trials.
    Sahay S; Nombela-Franco L; Rodes-Cabau J; Jimenez-Quevedo P; Salinas P; Biagioni C; Nuñez-Gil I; Gonzalo N; de Agustín JA; Del Trigo M; Perez de Isla L; Fernández-Ortiz A; Escaned J; Macaya C
    Heart; 2017 Jan; 103(2):139-147. PubMed ID: 27587437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4-Year Outcomes After Left Atrial Appendage Closure Versus Nonwarfarin Oral Anticoagulation for Atrial Fibrillation.
    Osmancik P; Herman D; Neuzil P; Hala P; Taborsky M; Kala P; Poloczek M; Stasek J; Haman L; Branny M; Chovancik J; Cervinka P; Holy J; Kovarnik T; Zemanek D; Havranek S; Vancura V; Peichl P; Tousek P; Lekesova V; Jarkovsky J; Novackova M; Benesova K; Widimsky P; Reddy VY;
    J Am Coll Cardiol; 2022 Jan; 79(1):1-14. PubMed ID: 34748929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual therapy with oral anticoagulation and single antiplatelet agent versus monotherapy with oral anticoagulation alone in patients with atrial fibrillation and stable ischemic heart disease: a systematic review and meta-analysis.
    Shakir A; Khan A; Agarwal S; Clifton S; Reese J; Munir MB; Nasir UB; Khan SU; Gopinathannair R; DeSimone CV; Deshmukh A; Jackman WM; Stavrakis S; Asad ZUA
    J Interv Card Electrophysiol; 2023 Mar; 66(2):493-506. PubMed ID: 36085242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left atrial appendage closure for prevention of death, stroke, and bleeding in patients with nonvalvular atrial fibrillation.
    Gloekler S; Saw J; Koskinas KC; Kleinecke C; Jung W; Nietlispach F; Meier B
    Int J Cardiol; 2017 Dec; 249():234-246. PubMed ID: 28882323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Latest outcomes of transcatheter left atrial appendage closure devices and direct oral anticoagulant therapy in patients with atrial fibrillation over the past 5 years: a systematic review and meta-analysis.
    Takeda K; Tsuboko Y; Iwasaki K
    Cardiovasc Interv Ther; 2022 Oct; 37(4):725-738. PubMed ID: 35098478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left Atrial Appendage Closure as an Alternative to Warfarin for Stroke Prevention in Atrial Fibrillation: A Patient-Level Meta-Analysis.
    Holmes DR; Doshi SK; Kar S; Price MJ; Sanchez JM; Sievert H; Valderrabano M; Reddy VY
    J Am Coll Cardiol; 2015 Jun; 65(24):2614-2623. PubMed ID: 26088300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thromboembolism after electrical isolation of the left atrial appendage: a new indication for interventional closure?
    Zender N; Weise FK; Bordignon S; Herrmann E; Konstantinou A; Bologna F; Nagase T; Chen S; Chun KRJ; Schmidt B
    Europace; 2019 Oct; 21(10):1502-1508. PubMed ID: 31230078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left atrial appendage closure: a new strategy for cardioembolic events despite oral anticoagulation.
    Falasconi G; Gaspardone C; Godino C; Gaspardone A; Radinovic A; Pannone L; Leo G; Posteraro GA; Slavich M; Melillo F; Marzi A; D'Angelo G; Limite LR; Frontera A; Brugliera L; Agricola E; Margonato A; Della Bella P; Mazzone P
    Panminerva Med; 2023 Jun; 65(2):227-233. PubMed ID: 34664480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current State of Left Atrial Appendage Closure.
    Kosturakis R; Price MJ
    Curr Cardiol Rep; 2018 Apr; 20(6):42. PubMed ID: 29680999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral anticoagulation and left atrial appendage closure: a new strategy for recurrent cardioembolic stroke.
    Masjuan J; Salido L; DeFelipe A; Hernández-Antolín R; Fernández-Golfín C; Cruz-Culebras A; Matute C; Vera R; Pérez-Torre P; Zamorano JL
    Eur J Neurol; 2019 May; 26(5):816-820. PubMed ID: 30586229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Residual stroke risk after left atrial appendage closure in patients with prior oral anticoagulation failure.
    Pracoń R; Zieliński K; Bangalore S; Konka M; Kruk M; Kępka C; Trochimiuk P; Dębski M; Przyłuski J; Kaczmarska E; Dzielińska Z; Kurowski A; Witkowski A; Demkow M
    Int J Cardiol; 2022 May; 354():17-21. PubMed ID: 35219744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.